| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/12/2004 | US20040028684 Cancer diagnosis and assays for screening anti-cancer agents |
| 02/12/2004 | US20040028677 Chimeric allograft tolerance induction, monitoring and maintenance |
| 02/12/2004 | US20040028675 Compositions for the treatment of lupus |
| 02/12/2004 | US20040028673 Compositions and methods for prevention and treatment of amyloid-beta peptide-related disorders |
| 02/12/2004 | US20040028672 Calibration of infection therapy measuring proteinase; antiulcer agents; wound healing agent |
| 02/12/2004 | US20040028669 Human gene critical to fertility |
| 02/12/2004 | US20040028668 Food supplement with a slimming effect |
| 02/12/2004 | US20040028660 Methods of using JNK or MKK inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromes |
| 02/12/2004 | US20040028658 Methods of organ regeneration |
| 02/12/2004 | US20040028645 Artificial tear composition adapted to be used with contact lenses |
| 02/12/2004 | US20040028644 Synergistic mixture |
| 02/12/2004 | US20040028639 Cholesterol sulfate compositions for enhancement of stratum corneum function |
| 02/12/2004 | US20040028631 Cosmetic formulations |
| 02/12/2004 | US20040028627 Mixture of hydroquinone and ascorbic compound |
| 02/12/2004 | US20040028626 Photoprotective UV-screening compositions comprising triazine/dibenzoylmethane/diarylbutadiene compounds |
| 02/12/2004 | US20040028625 Transdermal delivery of analgesics |
| 02/12/2004 | US20040028619 Antiinflammatory agents; bronchodilator agents; antihistamines; respiratory system disorders |
| 02/12/2004 | US20040028618 Powder aerosol mixture containing propellant gas mixtures |
| 02/12/2004 | US20040028617 Mixture with alcohol carrier; administering to drug nose mucous membrane; side effect reduction |
| 02/12/2004 | US20040028616 Dna-polyethylenimine complex; aerosol administering gene and anticancer agents |
| 02/12/2004 | US20040028615 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 02/12/2004 | US20040028610 Administering androgen |
| 02/12/2004 | US20040025876 Capsules for dry powder inhalers and methods of making and using same |
| 02/12/2004 | DE19949252B4 Verwendung eines superfiziellen therapeutischen Systems zur topischen Applikation von Acetylsalicylsäure zur Behandlung von Akne-Erkrankungen und Verfahren zu seiner Herstellung Use of a superficial therapeutic system for the topical application of acetylsalicylic acid for the treatment of acne diseases and process for its preparation |
| 02/12/2004 | DE10251709A1 Wirkstoffe zur Stimulierung der humanen beta-Defensine vom Typ 2 und/oder Typ 3 und kosmetische oder pharmazeutische Zusammensetzungen, die solche Wirkstoffe enthalten Agents for stimulating the human beta-defensins type 2 and / or Type 3 and cosmetic or pharmaceutical compositions containing such active |
| 02/12/2004 | DE10236096A1 Composition comprising chloramine T and/or chloramine B, e.g. useful for disinfection and bleaching, includes an additive for reducing the chloramine odor |
| 02/12/2004 | DE10234531A1 Use of a mixture of citric acid, sodium citrate and potassium bicarbonate to prepare a medicament for treating sun allergy |
| 02/12/2004 | DE10234424A1 Benzothiophen-, Benzofuran- und Indolharnstoffe Benzothiophene, benzofuran and Indolharnstoffe |
| 02/12/2004 | DE10234201A1 Treatment of neuroendocrine or gastrointestinal tumors, using agents taken up by the monoamine transporter or benzodiazepine receptor |
| 02/12/2004 | DE10233994A1 Kosmetische oder pharmazeutische Zubereitungen enthaltend Nukleinsäuren auf der Basis nicht-methylierter CpG-Motive Cosmetic or pharmaceutical preparations containing nucleic acids based on non-methylated CpG motifs |
| 02/12/2004 | DE10233412A1 Neue Verbindungen als Histondeacetylase-Inhibitoren New connections as histone deacetylase inhibitors |
| 02/12/2004 | DE10233366A1 In 6-Stellung substituierte Indolinonderivate, ihre Herstellung und ihre Verwendung als Arzneimittel In the 6-position substituted indolinone derivatives, their preparation and their use as medicaments |
| 02/12/2004 | DE10233342A1 Synergistic cholesterol lowering composition, useful as medicament or food or feed additive, comprising dietary fiber component and ahypocholesterolemic agent, e.g. statin |
| 02/12/2004 | DE10233229A1 Pharmazeutische Zusammensetzung zur Senkung des Triglyceridspiegels A pharmaceutical composition for lowering triglyceride levels |
| 02/12/2004 | CA2495447A1 Anti-microbial compositions and methods of using same |
| 02/12/2004 | CA2494837A1 Novel druggable regions in set domain proteins and methods of using the same |
| 02/12/2004 | CA2494801A1 Medicinal composition containing hmg-coa reductase inhibitor |
| 02/12/2004 | CA2494632A1 3-amino-2-hrydroxyalkanoic acids and their prodrugs |
| 02/12/2004 | CA2494616A1 Furanthiazole derivatives as heparanase inhibitors |
| 02/12/2004 | CA2494421A1 Condensed pyridines and pyrimidines with tie2 (tek) activity |
| 02/12/2004 | CA2494408A1 Method and compounds for promoting healing and reducing inflammation |
| 02/12/2004 | CA2494378A1 Physiologically balanced, ionized, acidic solution and methodology for use in wound healing |
| 02/12/2004 | CA2494348A1 Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels |
| 02/12/2004 | CA2494288A1 Novel salt and polymorphs of desloratadine hemifumarate |
| 02/12/2004 | CA2494284A1 Methods for treatment and prevention of gastrointestinal conditions |
| 02/12/2004 | CA2494281A1 Sustained release formulations of metformin |
| 02/12/2004 | CA2494214A1 Conjugates of porphyrin compounds with chemotherapeutic agents |
| 02/12/2004 | CA2494211A1 Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration |
| 02/12/2004 | CA2494146A1 The 9, 11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma |
| 02/12/2004 | CA2494139A1 Biaryl compounds having anti-infective activity |
| 02/12/2004 | CA2494114A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 02/12/2004 | CA2494074A1 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 02/12/2004 | CA2493752A1 Papsss as modifiers of the axin pathway and methods of use |
| 02/12/2004 | CA2493737A1 2-substituted bicyclic benzoheterocyclic compounds and their use as sodium channel blockers |
| 02/12/2004 | CA2493637A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/12/2004 | CA2493618A1 Nitrosated proton pump inhibitors, compositions and methods of use |
| 02/12/2004 | CA2493593A1 Bicifadine formulation |
| 02/12/2004 | CA2493551A1 Aminoalkyl-substituted aryl compounds and their use as sodium channel blockers |
| 02/12/2004 | CA2493301A1 Sustained release formulations comprising lamotrigine |
| 02/12/2004 | CA2493289A1 A pharmaceutical formulation and its use in the treatment of inner ear diseases |
| 02/12/2004 | CA2493253A1 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy |
| 02/12/2004 | CA2492949A1 Crystalline polymorphic and amorphous forms of benazepril hydrochloride |
| 02/12/2004 | CA2492830A1 Pyrrolidine derivatives as tryptase inhibitors |
| 02/12/2004 | CA2491366A1 Improved transdermal delivery system for the administration of rotigotine |
| 02/12/2004 | CA2397684A1 Mitochondrially targeted antioxidants |
| 02/11/2004 | EP1388542A1 Use of hederagenin 3-0-alpha-L-rhamnopyranosyl(1-2[beta-D-glucopyranosyl(1-4)]-alpha-L-arabinopyranoside or an extract from pulsatillae radix containing the same as a therapeutic agent for solid tumors |
| 02/11/2004 | EP1388541A1 Pyrrolopyrazines as kinase inhibitors |
| 02/11/2004 | EP1388537A1 Arginine derivatives |
| 02/11/2004 | EP1388535A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 02/11/2004 | EP1388534A2 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors |
| 02/11/2004 | EP1388352A1 Use of a ppar-alpha agonist to treat patients suffering from weight gain associated with a ppar-gamma agonist treatment |
| 02/11/2004 | EP1388351A1 Use of fibrate to treat weight gain associated with rosiglitazone treatment |
| 02/11/2004 | EP1388347A1 Multilayered elastomer material containing a chemical active substance and applications thereof |
| 02/11/2004 | EP1388344A1 Composition comprising Salvia Miltiorrhizae, Ginseng, Borneol for treating heart disease, and cerebrovascular diseases |
| 02/11/2004 | EP1388343A1 Antioxidant composition and method of preparation thereof |
| 02/11/2004 | EP1388342A1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 02/11/2004 | EP1388341A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 02/11/2004 | EP1388340A1 Compositions for transmucosal administration containing coenzyme q as the active ingredient |
| 02/11/2004 | EP1388295A1 Cereal based food product comprising DHA |
| 02/11/2004 | EP1387895A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 02/11/2004 | EP1387892A2 Gene delivery compounds |
| 02/11/2004 | EP1387850A2 Antiviral nucleosides |
| 02/11/2004 | EP1387844A1 Retinol derivatives potentiation of active substances by micellar preparation |
| 02/11/2004 | EP1387843A1 Method for obtaining pioglitazone as an antidiabetic agent |
| 02/11/2004 | EP1387842A1 Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors |
| 02/11/2004 | EP1387841A1 Novel azole or triazole derivatives, method for preparing same and use thereof as fungicides |
| 02/11/2004 | EP1387840A1 3,5-diamino-1,2,4-triazoles as kinase inhibitors |
| 02/11/2004 | EP1387839A1 Process for the production of quinazolines |
| 02/11/2004 | EP1387838A1 Cyanoanthranilamide derivatives and the use thereof as medicaments |
| 02/11/2004 | EP1387837A1 Novel azole or triazole derivatives, method for preparing same and use thereof as antifungal medicines |
| 02/11/2004 | EP1387836A1 Phthalazine derivatives with angiogenesis inhibiting activity |
| 02/11/2004 | EP1387830A1 Novel 4-anilinoquinoline-3-carboxamides |
| 02/11/2004 | EP1387829A1 Novel pyridinone and related heterocyclic derivatives |
| 02/11/2004 | EP1387826A1 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors |
| 02/11/2004 | EP1387825A1 Thyroid hormone receptor antagonists for cardiac & metabolic disorders ii |
| 02/11/2004 | EP1387821A2 Estrogen receptor modulators |
| 02/11/2004 | EP1387694A2 Composition and method for treating cancer using herpes virus |
| 02/11/2004 | EP1387690A1 Use of extracts and preparations from iris plants and tectorigenin as medicaments |
| 02/11/2004 | EP1387689A1 Combination of a gelatinase inhibitor and an anti-tumor agent, and uses thereof |
| 02/11/2004 | EP1387688A2 Benzazepinone alpha v integrin receptor antagonists |